Dora Bocangel
About
In The Last Decade
Dora Bocangel
17 papers receiving 900 citations
Peers
Comparison fields: 5 of 75
- Molecular Biology 513
- Oncology 334
- Genetics 215
- Genetics 167
- Immunology 155
Countries citing papers authored by Dora Bocangel
This map shows the geographic impact of Dora Bocangel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dora Bocangel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dora Bocangel more than expected).
Fields of papers citing papers by Dora Bocangel
This network shows the impact of papers produced by Dora Bocangel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dora Bocangel. The network helps show where Dora Bocangel may publish in the future.
Co-authorship network of co-authors of Dora Bocangel
This figure shows the co-authorship network connecting the top 25 collaborators of Dora Bocangel. A scholar is included among the top collaborators of Dora Bocangel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dora Bocangel. Dora Bocangel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | p53-Mediated down-regulation of the human DNA repair gene O6-methylguanine-DNA methyltransferase (MGMT) via interaction with Sp1 transcription factor. | 80 |
| 2 | 43 | |
| 3 | 20 | |
| 4 | 21 | |
| 5 | 38 | |
| 6 | 21 | |
| 7 | 16 | |
| 8 | 49 | |
| 9 | 14 | |
| 10 | 44 | |
| 11 | 56 | |
| 12 | 89 | |
| 13 | 105 | |
| 14 | 0 | |
| 15 | Multifaceted resistance of gliomas to temozolomide. | 115 |
| 16 | Thresholds of O6-alkylguanine-DNA alkyltransferase which confer significant resistance of human glial tumor xenografts to treatment with 1,3-bis(2-chloroethyl)-1-nitrosourea or temozolomide. | 72 |
| 17 | 119 | |
| 18 | 8 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.